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Abstract
In vertebrates the microtubule-associated proteins MAP6 and MAP6d1 stabilize cold-resistant microtubules. Cilia and
flagella have cold-stable microtubules but MAP6 proteins have not been identified in these organelles. Here, we describe
TbSAXO as the first MAP6-related protein to be identified in a protozoan, Trypanosoma brucei. Using a heterologous
expression system, we show that TbSAXO is a microtubule stabilizing protein. Furthermore we identify the domains of the
protein responsible for microtubule binding and stabilizing and show that they share homologies with the microtubule-
stabilizing Mn domains of the MAP6 proteins. We demonstrate, in the flagellated parasite, that TbSAXO is an axonemal
protein that plays a role in flagellum motility. Lastly we provide evidence that TbSAXO belongs to a group of MAP6-related
proteins (SAXO proteins) present only in ciliated or flagellated organisms ranging from protozoa to mammals. We discuss
the potential roles of the SAXO proteins in cilia and flagella function.
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Introduction
The cytoskeleton of eukaryotic cells is essential to maintain cell
structure and polarization, and to optimize membrane dynamics,
intracellular transport, cell division, and locomotion. In higher
eukaryotes, the cytoskeleton is mainly composed of actin
microfilaments, intermediate filaments and microtubules (MTs).
MTs are dynamic tubulin polymers where the balance between
assembly and disassembly of protofilaments is precisely regulated
by microtubule-associated proteins (MAPs) [1]. In vertebrates
most MTs will disassemble at low temperature but some remain
cold-stable or resistant to drugs such as nocodazole [2,3]. It has
been shown that the stability of MTs that are cold- and
nocodazole-resistant is largely due to their association with the
class of MAP known as MAP6 (previously named STOP for Stable
Tubule Only Polypeptide) and MAP6d1 (previously named SL21
for STOP-Like of 21 kD) [2,4,5]. MAP6 and MAP6d1 proteins
(designated in this paper as MAP6s) are expressed only in
vertebrates [6], and have been localized in neurons, astrocytes,
oligodendrocytes, fibroblasts, and several tissues (including heart,
muscle, lung, and testis) [4,7,8,9]. MAP6 is expressed as three
isoforms (MAP6-1, -2, -3) [2]. These MAPs interact with MTs
through their MT binding modules called Mn and Mc: MT
resistance to both cold and nocodazole disassembly is via the Mn
modules, and cold resistance only is via the Mc modules.
Interestingly, the Mn modules are well conserved in MAP6
proteins amongst vertebrates, whereas Mc modules are only found
in mammals and are the result of a defined insertion in exon 1
[2,6]. MAP6s modules are bi-functional since MT-stabilizing
domains and calmodulin-binding domains overlap to some extent
allowing a steric regulation for MT binding as described in vitro
and in vivo [4,6]. Additionally, when phosphorylated, MAP6-1 does
not bind to microtubules in vitro and co-localizes with actin
filaments in vivo suggesting, as for MAP2c (a mammalian neuronal
MAP), a role in neurite initiation [10,11,12]. MAP6s share a N-
terminal cysteine-rich sequence, which, when palmitoylated,
targets these proteins to the Golgi apparatus [2,4]. Map6-null
mice exhibit a set of defects similar to those of schizophrenia
disorders; thus the loss of Map6 is not lethal but is clearly central
for normal synaptic plasticity [13]. Taken together, these data
indicate a high level of MAP6s regulation.
Trypanosoma brucei (T. brucei) is a flagellated protozoan parasite
that causes human sleeping sickness and Nagana disease in
livestock in central and southern Africa. It belongs to the
Kinetoplastidae order of protozoa (characterized by the presence
of a kinetoplast, the single mitochondrion genome associated with
the base of the flagellum), which includes Trypanosoma cruzi and
different species of Leishmania that are responsible for Chagas
disease and leishmaniasis respectively [14]. The T. brucei
cytoskeleton is composed of a subpellicular corset of about 100
MTs underlying the plasma membrane, the mitotic spindle (MS)
in mitotic cells, and a single flagellum [15,16]. In the flagellum, the
MTs form the canonical axoneme with 9 outer triplets of MTs at
the basal bodies level followed by the 9 outer doublets at the
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central pair of MTs (9+2) that is characteristic of motile cilia [17].
The flagellum of trypanosomes participates in a wide variety of
functions, from cell mobility to host-parasite interaction (for
reviews see [18,19]). It is a highly complex organelle - a proteomic
analysis of its cytoskeleton has resulted in the identification of 331
proteins, many of which are conserved in other kinetoplastids and
higher eukaryotes [20]. The kinetoplastid flagellum possesses a
prominent structure called the paraflagellar rod (PFR), which runs
along the axoneme from the point at which the flagellum exits the
cell to its distal tip [21] and, which is required for normal flagellum
motility [22,23,24,25,26].
The MT arrays of trypanosomes are highly resistant to
depolymerization upon cold treatment [27,28] and have a low
sensitivity to nocodazole [29,30]. In T. brucei, several MAPs have
been characterized, but notably none have been described as
being flagellar specific [20,31,32,33,34,35,36,37].
In eukaryotes, the MT-based organelles centrioles, cilia and
flagella MT have cold-resistant MTs [38,39,40,41,42]. The
processes regulating cilia and flagella stability are not fully
understood but may involve tubulin post-translational modifica-
tions [43,44]. Also, several proteins are involved in their stability
such as the ribbon protofilament proteins [45,46,47]. The ribbon
protofilament protein Rib43a is conserved in trypanosomes [48]
and is found in the cytoskeletal fraction of the flagellum, but has
not been studied [20,49,50].
In this study, we present TbSAXO (for T. brucei STOP
Axonemal protein) as the first MAP6-related protein identified
in a protozoan. We demonstrate that it is an axonemal MAP
involved in flagellar motility in T. brucei. In addition, our analysis
indicates that TbSAXO belongs to a unique group of MAP6-
related proteins (SAXO proteins) that are present only in ciliated
or flagellated organisms ranging from protozoa to mammals,
which suggests for the SAXO proteins unique functions in cilia
and flagella of eukaryotes.
Results
Identification of MAP6-related proteins from protozoa to
mammals
During a proteomic analysis of T. brucei flagellar proteins
[51,52], we identified a 30 kD basic protein (GeneDB accession
number Tb927.8.6240). Based on the study (described below), we
designated this protein as TbSAXO. TbSAXO is listed in a
trypanosome flagella proteome analysis as orthologous to an
unknown Plasmodium falciparum protein (PFI0460w), that we
designate here PfSAXO [20].
A BLAST analysis, using the TbSAXO sequence, identified
orthologues throughout the taxonomic categories and ranged from
protozoa to mammals (Fig. S5). Those orthologs were present only
in ciliated or flagellated eukaryotes, with the exception of
Cryptosporidium, a parasitic non-flagellated, non-ciliated protozoan.
Also we were not able to identify orthologues neither in
prokaryotes, fungi, nor in the flagellates Naegleria, Phytophthora
and Monosiga.
We analyzed the protein primary sequences of TbSAXO,
PfSAXO and MmSaxo1 (one of the two orthologs identified in
mouse) and identified four shared amino acid features: 1) a high
percentage of proline (13.2%, 20% and 11.6% respectively); 2) a
cluster of cysteines at the N-terminus (motif 1); 3) a ,15 amino
acid repeated domain, which is highly conserved in PfSAXO
(motif 2) (Fig. 1A, B); and 4) all three SAXO proteins have a basic
calculated pI of 8.95, 8.25, 9.05 for TbSAXO, PfSAXO and
MmSaxo1 respectively [53]. We did not identify any canonical
proline-recognition domains in TbSAXO or PfSAXO, but
repeated proline-rich sequences in both proteins as well as several
proline-recognition domains (SH2 and SH3 binding domains,
data not shown) in MmSaxo1 are indicative of a role in protein-
protein interaction [54].
Analysis of the primary sequences of MmMap6s, TbSAXO,
PfSAXO and MmSaxo1 indicated that these proteins displayed
similar characteristics: 1) a N-terminal domain sequence (motif 1)
with a cluster of cysteines (Fig. 1A), and, 2) a repeated domain of
15 amino acids (motif 2) that shared some conserved residues with
the MT binding and stabilizing Mn module of MAP6 proteins.
The motif 2 is followed by an inter-repeat region (IR) of ,18–20
residues, which is highly conserved in PfSAXO (Fig. 1B).
Additionally, we used the motif analysis tool MEME [55,56] with
mouse Map6-1, Map6d1, MmSaxo1, PfSAXO, TbSAXO and
several other protozoan sequences identified by BLAST to further
characterize these proteins, in particular the protozoan proteins
(Fig. 1C). Keeping in mind that the highly conserved repeat
sequence in PfSAXO introduces a strong bias (Fig. 1B), and in
spite of this, the analysis identified a regular expression of 2 motifs
corresponding to motif 1 ([GR][KT]CVC[ESR][LI]CTCGK[HC][KR]C)
and motif 2 ([PK]SLPFE[GA]E[TS][NT]YRS[ED][FY]GPKPLP[EP]L)
(Fig. 1A, B). As shown in Figure 1C, motif 1 is present in the
protozoan sequences and the MmSaxo1 sequence but absent in
Map6-1 and Map6d1 sequences demonstrating its specificity for a
distinct group of proteins (SAXO proteins) despite the common
presence of cysteines. Motif 2 is repeated and common to all
sequences including the mouse Map6s. This latter motif
corresponds partially to the MAP6s Mn modules that are involved
in MT resistance to both cold and nocodazole depolymerization
that were identified experimentally [6] (Fig. 1B). We thus named
the regions containing the motif 2 of TbSAXO, PfSAXO and
MmSaxo1 Mn-like motifs (MnL). Based on the highly conserved
T/S and F/Y residues respectively at positions 6 and 12 of motif 2,
we manually identified additional putative MnL domains (Fig. 1B
sequences in italic, Fig. 1C motif 2 manual). We identified 6 MnL
domains in TbSAXO and 12 domains in PfSAXO and MmSaxo1
(Fig. 1B). The C-terminal MnL domains have a longer sequence
than the other MnL domains and bare a short Cysteine-Proline
motif (CP). We thus differentiate these domains by an asterisk
MnL-x* (Fig. 1B, C). Interestingly, the MEME analysis identifies a
fourth Mn (or MnL) domain in Map6-1, which has not been
identified previously and which experimentally does not seem to
be functional [6].
Taken together, these data suggest that the identified SAXO
proteins form a family of MAP6-related proteins in ciliated/
flagellated organisms present in protozoa to mammals, and that
they are organized as follows: the N-terminus bears a cysteine-rich
motif 1 followed by a linear repetition of MnL motifs, the most C-
terminal one carrying an additional Cysteine-Proline motif.
TbSAXO is an axoneme specific protein in the protozoan
T. brucei
During the T. brucei cell cycle, the new flagellum originates
from the newly formed basal body and grows through the
flagellar pocket (see diagram of a T. brucei cell, Fig. 2A). At the
point of exit from the pocket, the flagellum bares the PFR, an
accessory structure that is involved in flagellum motility, and is
common to some flagellated protists [21]. In the context of the
complex flagellum organization and in order to investigate the
location and function of TbSAXO in detail, we cloned the gene
and produced a polyclonal and a monoclonal antibody (mAb25).
Western-blot (WB) analysis on T. brucei whole procyclic form
(PCF) cells and bloodstream form (BSF) cells using the polyclonal
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to TbSAXO and that TbSAXO was expressed in both parasite
forms (Fig. 2B). Furthermore, TbSAXO was associated with the
cytoskeleton fraction of the flagellum since detergent and salt
extraction during the preparation of cytoskeletons and flagella did
not remove the protein (Fig. 2C). In addition, WB studies
indicated that TbSAXO migrates as a doublet suggesting that one
or more post-translational modifications are present on the
protein (Fig. 2C).
In both PCF and BSF developmental stages, TbSAXO was
observed by immuno-fluorescence (IF) to localize along the
flagellum (Fig. 3 for PCF, Fig. S4 for BSF). Fluorescence signal
extended from the transition zone of the axoneme to the distal tip
of the flagellum as shown by the co-labeling with the well-
established transition zone antibody FTZC [57] and the anti-
PFR2 antibody L8C4 [58] (Fig. 3A, B). TbSAXO was also present
in both the old and new flagella in dividing cells (Fig. 3B and Fig.
S4). The flagellar signal was visible even when the short, new
flagellum was entirely within the flagellar pocket; this was
confirmed by the absence of PFR labeling on the new flagellum
(Fig. 3B, 1K1N2F). Double labeling of the PFR and TbSAXO
suggested that TbSAXO is an axoneme-associated protein, in that
TbSAXO localization extends past the PFR, is proximal to the
transition zone, and there was no over-lap or co-localization along
the length of the flagellum beside some parts of the flagellum due
to the orientation of the cell when observed by immuno-
fluorescence (Fig. 3A, B). Further, immuno-electron labeling of
PCF flagella revealed mAb25 labeling all over the axoneme
(Fig. 3Ca, b, c). Unfortunately, the stronger fixation conditions
required for whole cell preparation prevented immuno-labeling of
sectioned material.
TbSAXO is a microtubule-associated and microtubule-
stabilizing protein
We have shown that TbSAXO is an axoneme-associated protein
in the parasite with primary sequence characteristics similar to
those of the MAP6s; thus we asked the question could it function
in MT binding and/or stabilization?
To study TbSAXO MT stabilizing functions directly, and to
circumvent the fact that the trypanosome cytoskeleton is
unusually stable [20,27,29,30], we expressed a recombinant
TbSAXO-Myc protein in the U-2 OS human cell line (human
bone osteosarcoma epithelial cells) [59]. As with many mamma-
lian cell lines, when U-2 OS cells in culture are incubated either
at 4uC or in the presence of nocodazole, interphase MTs
depolymerize (Fig. S1A, B). To validate the use of the U-2 OS
cell system for our purposes, we transfected them with a vector
allowing the expression of the rat MAP6-1-GFP protein. After
24 h post-transfection, the cells were briefly detergent-extracted
then fixed. At 37uC MAP6-1-GFP was expressed in U-2 OS cells
and decorated the interphase MTs (Fig. 4a). After cold or
Figure 2. TbSAXO is a cytoskeleton protein in T. brucei. A.
Schematic diagram of a T. brucei cell in interphase. (N) nucleus, (K) a
single kinetoplast, (F) a single flagellum, (A) a single axoneme, and PFR
the single paraflagellar rod. Note that the distal end of the flagellum
emerges from the flagellar pocket located at the posterior end of the
cell and is then external to the cell body. B. Specificity of the polyclonal
serum and the monoclonal antibody mAb25 for TbSAXO. Pre-immune
and immune sera were tested on 1.10
6 PCF and BSF cells and 40 ng of
the purified recombinant Histidine-tagged TbSAXO (His-SAXO) demon-
strating the specificity of the immune serum. The derived monoclonal
antibody mAb25 is also specific to TbSAXO as shown on PCF and BSF
cells, histidine-tagged recombinant protein as well as PCF cells
overexpressing a GFP-tagged TbSAXO (calculated MW 57.3 kD). The
loading control was done with the L8C4 antibody, which identifies PFR2
protein. C. The monoclonal antibody mAb25 identifies TbSAXO on 3.10
6
PCF whole cells (WC), cytoskeletons (CK) and flagella (FG). The
membranes were probed simultaneously with mAb25 and the loading
control anti-PFR2.
doi:10.1371/journal.pone.0031344.g002
Figure 1. Identification of SAXO proteins, a MAP6-related protein family. A. Motif 1. The N-terminal domain and its cysteine consensus
sequence. Left panel: alignment of the N-terminal sequences of the proteins used for the MEME analysis in C. The boxed sequences correspond to
motif 1. Amino acids corresponding to the regular expression of motif 1 are shown in blue. Right panel: motif 1 is represented as a position-specific
probability matrice derived from the MEME analysis in C. B. Motif 2. Mn domains in mouse Map6-1, Map6d1, and Mn-like domains and inter-repeats in
mouse Saxo1, Plasmodium SAXO and Trypanosoma SAXO. Left panel: characters in blue correspond to the regular expression of the Mn and Mn-like
domains identified by the MEME analysis in C; the Mn-like domains identified manually are in italics. The underlined sequences in Map6-1 and
Map6d1 correspond to the experimentally identified Mn domains in mouse [4,6]. CP motifs are boxed. IR: inter-repeat regions. Right panel: the Mn-
like regular expression is represented as position-specific probability matrix derived from MEME analysis in C. C. Identification of a family of proteins
containing Mn-Like domains. MEME analysis using mouse Map6s, mouse Saxo1, and only protozoan SAXO sequences identified a characteristic N-
terminal motif (motif 1, dark blue boxes) in SAXO proteins and Mn-like domains (motif 2, light blue boxes) common to the SAXO and MAP6 proteins.
Manually identified supplementary motifs 2 are in grey boxes (Motif 2 manual). The asterisk indicates a conserved CP sequence in the last Mn-like
domain.
doi:10.1371/journal.pone.0031344.g001
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displayed a network of MTs, demonstrating that the MAP6
protein had stabilized the MTs (Fig. 4a, Fig. S1b).
We next transfected the cells with the TbSAXO-Myc expression
vector to study its potential to stabilize MTs. At 24 h post
transfection, the cells were extracted and fixed and TbSAXO-Myc
was detected by immuno-staining using an anti-Myc antibody. At
37uC, TbSAXO-Myc decorated the MT network (Fig. 4b), similar
to what we had observed with MAP6-1-GFP transfection
demonstrating that TbSAXO can function as a microtubule-
associated protein in a heterologous system, and can interact with
interphase MTs at 37uC. We never observed TbSAXO-Myc
labeling on the mitotic spindle or at the midbody, suggesting some
specificity for interphase MTs in this system. After cold (4uC)
treatment, we observed the depolymerization of MTs in non-
transfected cells as would be expected, but in cells expressing
TbSAXO-Myc, stabilized MTs were observed to be decorated
with TbSAXO-Myc protein (Fig. 4b). In summary, these data
show that TbSAXO can act as a MT binding and stabilizing
protein.
The MnL motifs are required and sufficient for
microtubule binding and stabilization
One of the characteristics of MAP6s is the presence of a N-
terminal cysteine cluster, which can be palmitoylated and is
responsible for targeting to the Golgi apparatus [4]. We wanted to
determine if the N-terminus of TbSAXO was also involved in
targeting per se; thus, we first deleted the N-terminal domain
(TbSAXOD2-35-Myc). When TbSAXOD2-35-Myc was expressed
in U-2 OS cells, it co-localized with MTs at 37uC (Fig. 4c
[extracted cells] and Fig. S2c [non-extracted cells]), and stabilized
the MT network at 4uC (Fig. 4c) suggesting that the N-terminal
domain of TbSAXO is not required for MT targeting and binding.
Further, the N-terminal domain alone was not sufficient for MT
binding since TbSAXO-1-35-Myc did not bind to MTs at 37uCo r
4uC, and there was no MT stabilization at 4uC (Fig. 4d), although
expression of the recombinant protein was confirmed in non-
extracted cells (Fig. S2d). Finally, none of the full-length
(TbSAXO-Myc), the N-terminal domain (1–35-Myc) and the N-
terminal truncation (D2-35-Myc) proteins co-localized with
Giantin (a Golgi marker) in non-extracted cells. Thus, we can
conclude that the N-terminal domain is not involved in Golgi
targeting in this system (Fig. S6).
In TbSAXO, we identified 6 potential MnL domains (Fig. 1B).
We thus investigated the MT-stabilizing properties of the
repetitions MnL-1 to MnL-5 (as a block) and the MnL-6* domain
(which is longer than the other MnL domains and carries the CP
motif) by preparing Myc-tagged constructs and transfecting U-2
OS cells. The C-terminal domain deletion construct (DMnL-6*,
TbSAXOD214-266-Myc) did not co-localize with the MT network
at 37uC but co-localized with stabilized MTs after 4uC treatment
(Fig. 4e). It was thus clear that cold treatment induces a re-
localization of the recombinant protein, as previously observed for
Map6-3 in NIH3T3 cells [2]. The MnL6* domain (TbSAXO-214-
266-Myc) alone was not sufficient for MT targeting and or binding
and stabilization since MnL-6* was not associated with the
cytoskeleton in either experimental condition (Fig. 4f) although
expression of the recombinant protein was confirmed in non-
extracted cells (Fig. S2f).
Finally, we deleted the MnL-1 to MnL-5 motif block
(TbSAXOD36-213-Myc) and observed that there was no associ-
ation of this expressed protein with MTs at either 37uCo r4 uC
(Fig. 4g and Fig. S2g). Notably, expression of the block of MnL-1
to MnL-5 modules (TbSAXO-36-213-Myc) was able to restore the
MT targeting/binding and stabilizing functions after 4uC
treatment suggesting a cold-induced re-localization (Fig. 4h).
Figure 3. TbSAXO is an axoneme-associated protein in T. brucei.A . Immuno-labeling and localization of TbSAXO on PCF cytoskeletons. Left
panel: TbSAXO localization in the flagellum was identified by the mAb25 antibody (green). Labeling extends along the entire length of the flagellum
from the flagellar transition zone (*, labeled with the FTZC antibody) to the distal tip. The PFR is labeled red and begins where the flagellum exits the
cell (antibody L8C4). Right panel: a merge of IF and phase contrast. N: nucleus. K: kinetoplast. F: flagellum. Bar, 5 mm. B. Images of the proximal
flagellar regions of PCF cytoskeletons from cells through mitosis and cytokinesis. In each row, the left panel shows the PFR and FTZC (*) (red), the
center panel TbSAXO (green), and the right panel shows merged images. The cell cycle stages are defined as 1K1N1F (1 Kinetoplast, 1 Nucleus, 1
Flagellum), 1K1N2F, 2K1N2F and 2K2N2F in rows a–d respectively. TbSAXO labeling is present immediately distal to the FTZC and is clearly distinct
from PFR staining. Bar, 1 mm. C. Immuno-gold electron microscopy reveals that TbSAXO is localized in the axoneme. Mab25 immuno-gold particles
can be seen mainly on the axoneme and not on the PFR of flagella of PCF WT cells. Bars, 100 nm.
doi:10.1371/journal.pone.0031344.g003
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the MnL6* domain (TbSAXOD214-266-Myc and TbSAXO-36-
213-Myc) suggesting a role of this domain in MT-binding at 37uC.
Since MnL6* carries a specific Cysteine-Proline motif, we mutated
the CP motif to Glycine-Asparagine and showed that the mutation
did not affect the MT-binding and stabilizing properties of
TbSAXO-Myc (compare b and j in Fig. 4 and Figure S2). This
data shows that the CP motif is not involved in MT binding at
37uC and that another signal of unknown nature might be
involved.
Full-length or N-terminal deleted TbSAXO-dependent stabili-
zation of MTs was achieved in nocodazole treated cells but
required the MnL6 motif since the construct 36–213-Myc did not
stabilize microtubules after nocodazole treatment (Fig. S1B).
Further, mutation of the CP motif in MnL6* did not modify the
MT binding or stabilizing properties of TbSAXO after nocodazole
Figure 4. TbSAXO is a microtubule-associated protein and a microtubule-stabilizing protein. Mammalian cells (U-2 OS) expressing either
MAP6-1-GFP (row a), TbSAXO-Myc (row b), or various truncated versions of TbSAXO-Myc (rows c–j) (constructs are represented on the schemes on the
right panel). In each case, the transfected cells were incubated at 37uCo r4 uC to test for MTs cold stability. Anti-tubulin (TAT1) and anti-Myc
antibodies provided the images in left and centre columns respectively at each temperature. The right columns for each temperature set are merged
images. The cells were subjected to short extraction before fixation and immuno-labeling. TbSAXO MT stabilization is seen in images b, c, e, h and j.
MT stabilization is also observed in the positive control MAP6-1-GFP expressing cells (a). Nuclei were labeled with DAPI. Bar, 20 mm.
doi:10.1371/journal.pone.0031344.g004
TbSAXO, a MAP6-Related Protein in T. brucei
PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e31344treatment (Fig. S1Bg), suggesting that this motif is not involved in
the nocodazole-stabilizing property of the protein.
Finally, whilst being expressed in U-2 OS cells, the MnL6*
domain associated to MnL5 (180–266-Myc) was not able to bind
MT neither at 37uC nor at 4uC and did not induce cold or
nocodazole MT-stabilization suggesting that more than two MnL
domains are necessary (Fig. 4i, S1Bf and S2i).
These data demonstrate that the MnL motifs of TbSAXO do
share functional properties with the Mn domains of known MAP6
proteins. MnL6* and MnL5-MnL6* domains are not sufficient for
MT targeting/binding or stabilization but modules MnL-1 to
MnL-5 are sufficient for MT targeting/binding and stabilization
after cold treatment. This suggests that, unlike Map6d1 which has
only one Mn module to stabilize MTs, more than two MnL
modules might be required for MT binding and stabilization in
TbSAXO.
The MnL-1-5 domains are required for flagella targeting/
binding in T. brucei
Because of the high stability of trypanosome MTs, the MT
stabilization properties of TbSAXO could not be directly assessed
in the parasite, but, we investigated the domain(s) involved in
flagellum targeting and binding. We transfected procyclic
trypanosomes with an over-expression vector allowing the
inducible expression of various TbSAXO-Myc truncations of the
protein (schematically represented in Fig. 5). For all the transfected
cell lines studied, none of the trypanosome (non-induced or
induced) developed any growth phenotypes when compared to the
non-transfected parental cell line (WT) (data not shown). All Myc-
constructs were expressed upon induction as shown by WB using
whole cells probed with anti-Myc antibody (Fig. 5) and by IF (Fig.
S3). Immuno-fluorescence experiments on cytoskeleton-extracted
cells (Fig. 5) and on whole cells (Fig. S3) showed that, for all
constructs, a pool of Myc-tagged protein was found to be soluble,
localized in the cytoplasm, and was extracted during the
cytoskeleton preparations.
As shown on the WB in Figure 5a, the intensity of the full-length
over-expressed protein is only slightly reduced in induced flagella
compared to whole cells and cytoskeletons suggesting that most of
the recombinant protein is targeted to and associated with the
flagellum. After a short induction time of expression of
recombinant protein (3–6 h), the tagged TbSAXO was directed
to the new but not the old flagellum (Fig. 5a, IF panel) suggesting a
slow turnover of the protein or cell cycle dependent targeting.
Also, a weak IF signal was observed on the mitotic spindle (MS).
This labeling was never observed on WT cytoskeletons probed
with mAb25 but was also observed for over-expressed TbSAXO-
GFP (unpublished data) suggesting that TbSAXO-Myc is targeted
to the newly made flagellum, and that the MS targeting may be an
artifact of over-expression. Different expression levels were
observed between the truncated forms of recombinant
TbSAXO-Myc, as shown on WB (for example Fig. 5b versus
[5c]). Thus, it was not possible to directly compare the flagellar
MT affinity of these proteins when analyzing their expression
profiles in whole cells, cytoskeletons or flagella.
Our IF and WB data revealed that the MnL-1 to MnL-5 motif
block (TbSAXO-36-213-Myc) was necessary and sufficient to
target and to bind to the flagellum since its deletion
(TbSAXOD36-213-Myc) abolished the axoneme and the MT
location of the protein suggesting that the targeting/binding
domain has been removed (Fig. 5f, g). Further neither the N-
terminal motif 1 (TbSAXO-1-35-Myc) nor the MnL-6* domain
(TbSAXO-214-266-Myc) were necessary for flagellum targeting or
binding since their tagged version were soluble and their deletion
(TbSAXOD2-35-Myc, TbSAXOD214-266-Myc) did not affect the
axoneme location of the protein (Fig. 5b–e, Fig. S3). Since in vivo
expression of a small recombinant protein might be difficult
(TbSAXO-1-35-Myc is 10.2 kD), we expressed a C-terminus GFP-
tagged version (TbSAXO-1-35-GFP, 30.6 kD). Again, the motif 1-
GFP construct was produced as a soluble pool (unpublished data).
In contrast to TbSAXOD2-35-Myc and TbSAXOD214-266-Myc,
we did not detect any TbSAXO-36-213-Myc labeling at the MS,
even after longer induction times when both old and new flagella
were decorated (Fig. 5g, IF).
Taken together, these data demonstrate that the MnL domains
are required for targeting/binding to the flagellum but that neither
the MnL-6* nor motif 1, carrying the cysteine cluster, is required
for flagellum targeting or binding. Moreover, these findings
support the importance of multiple MnL domains for the MT
targeting that we have observed for TbSAXO in mammalian cells
(Fig. 4).
TbSAXO is involved in flagellum motility in T. brucei
To assess the functional role of TbSAXO in the parasite, we
used the tetracycline-inducible RNA interference (RNAi) system in
PCF and BSF cells (kind gifts from G. Cross, Rockefeller
University) [57,60,61,62]. Overall, a reduced growth rate was
observed for both non-induced PCF and BSF cell lines
transformed by the RNAi constructs compared to the non-
transformed parental cell line (WT) indicating that there is an
induction in the absence of tetracycline or, in other words, a leaky
induction of RNAi (Fig. 6a, e). Taking this into account, there was
no difference in growth rate observed in induced PCF cells
compared to non-induced cells (Fig. 6a). WB analysis of the
TbSAXO expression level showed that RNAi induction strongly
reduced the expression of TbSAXO in PCF while some reduction
of expression was also observed in non-induced cells when
compared to WT cells (Fig. 6b). This occurred in numerous
clones and after numerous transformations. In BSF cells, induction
of RNAi also strongly reduced the expression of TbSAXO (Fig. 6f),
some cells retained a very weak TbSAXO IF labeling after 72 h of
RNAi knockdown (multinucleate and anucleate cells in Fig. S4B),
but this is possibly the consequence of cell death within the 72 h
induction period and thus the absence of continued RNAi
knockdown.
Both life-cycle stages displayed different RNAi
TbSAXO pheno-
types but their flagella had consistent length and morphology
indicating that flagellar MTs were not destabilized when TbSAXO
expression is reduced. TbSAXO RNAi is not lethal in PCF cells,
however cell mobility was reduced since cells sedimented
suggesting a flagellar motility defect (Fig. 6c). Exemplified by
mobility traces (Fig. 6d) and supported by Movie S1, we confirmed
the motility defect by illustrating that the RNAi
TbSAXO cells
remained primarily in one location (,0.4 mm/sec) whilst the WT
cells travelled long distances (.10 mm/sec). The RNAi
TbSAXO cells
were not paralyzed, but the flagellar beat appeared uncoordinated
and slower when compared to WT (Movie S2). Also, a small
proportion of the PCF cells (5%) were either zoids (1 kinetoplast,
no nucleus) or multi-flagellated (4 flagella) indicating some
difficulties in cytokinesis when TbSAXO protein level was reduced
(Fig. S4A).
Cytokinesis defects have previously been described as a
consequence of RNAi knock-down of several proteins involved
in flagellar motility in BSF trypanosomes, such as PFR2, TAX-1
and Trypanin, resulting in cells with multiple nuclei and
kinetoplasts [20,63]. Even though induction of TbSAXO RNAi in
BSF was not unequivocally lethal, non-induced cells displayed a
slight reduction in growth rate, which was further accentuated in
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BSF cells (Fig. 6f) induced a cytokinesis-defective phenotype that
resulted in an accumulation of cells with aberrant numbers of
kinetoplasts, nuclei and flagella (Fig. 6g and Fig. S4B). Non-
induced (leaky) and induced cells initiated multiple S phase and
mitosis cycles but appeared to lack subsequent cytokinesis, or in
some cases underwent incorrect cytokinesis, leading to accumu-
lation of multinucleated cells and anucleated cells (zoids). The
multinucleated and multi-flagellated BSF cells (xKxNxF) had a
highly convoluted cell periphery and accumulation of vesicles of
unknown composition as observed by electron microscopy on thin-
sections (Fig. 6h). These aberrant cells are unlikely to recover to
the normal phenotype.
To summarize, these data demonstrate that TbSAXO is
involved in flagellum motility in PCF and as a consequence in
cytokinesis in both forms of T. brucei.
Discussion
In this study, we have identified TbSAXO as an axoneme-
specific MAP protein in the protozoan T. brucei. By analyzing its
primary sequence and performing functional analysis, we have
demonstrated that this protein has the characteristics of a
structural MAP. Further as discussed in detail below, identification
of a cysteine-rich N-terminal domain (motif 1), and of the Mn-like
domains (motif 2) involved in stabilization of MTs upon cold and
nocodazole treatments, suggests that TbSAXO is the first MAP6-
related protein to be identified in protozoa. TbSAXO co-localizes
with MTs (in both the parasite and mammalian cells), and when
expressed in mammalian cells, it stabilizes microtubules and
induces MT bundles as is observed for the expression of higher
eukaryotic structural MAPs in heterologous cells [64,65,66,67].
Knockdown of TbSAXO using RNAi
TbSAXO in its natural
context reduced flagellar motility suggesting that TbSAXO plays a
role in flagellar motility. The phenotypes induced by the
RNAi
TbSAXO (flagellar motility defect in PCF and cytokinesis
defect in BSF) are not unique; knock-down of other proteins
involved in flagellum motility in T. brucei [20,63,68] also produce
these phenotypes, even though Ralston et al. demonstrated
recently that normal flagellum motility is not required in BSF
[69]. Although flagellum motility (in PCF) and cytokinesis (in BSF)
are compromised in the RNAi
TbSAXO cell lines, no defect in
flagellum biogenesis, structure or MT stabilization was observed.
This suggests that some TbSAXO that remains after RNAi
TbSAXO
knockdown is sufficient, or that other protein(s) can compensate
for reduced levels of TbSAXO. TbSAXO may have more than one
function in trypanosomes. In mammalian cells, we have observed
that TbSAXO has intrinsic microtubule stabilization properties as
is the case for two other unrelated T. brucei MAPs (CAP15 and
CAP17) [36]. This suggests that TbSAXO may also contribute to
MT rigidity in the flagellum.
The structural MAPs Tau and Map2 have 3–4 repeats of ,30
amino acids in the microtubule-binding domain, each repeat
binding to tubulin. They stabilize microtubules by binding
longitudinally individual protofilaments [70,71]. Binding of Tau
or Map2c induces an increase of MT rigidity by changing the
mechanical properties of the polymer in vitro [72,73]. Our
observations suggest a similar mechanism for TbSAXO in flagellar
beat or flagellar motility in trypanosome. Our immuno-localiza-
tion and functional studies suggest that in the wild-type flagellum
TbSAXO binds to the protofilaments of outer doublets microtu-
bules, and modulates the rigidity of the polymer thus influencing
the beating properties of the flagellum. When TbSAXO level is
decreased (by RNAi), the flagellum beating properties may change
and are directly reflected by the motility phenotype observed in
PCF. From our IF studies, TbSAXO co-localizes with the 9+2
region of the axoneme (distal to the transition zone and continues
to the distal tip of the flagellum). The central pair of MTs and
associated proteins (also named the central apparatus) is
responsible for the motility of the axoneme in motile cilia and
flagella [74]. Modulation of the beating properties of the flagellum
via TbSAXO is thus coherent with its localization. TbSAXO could
therefore bind microtubules to modify or impose rigidity rather
than cold resistance. Additionally, the consequences of TbSAXO
RNAi may induce compensational modulation of flagellum beat or
stability by other proteins, and or may influence the role of the
PFR in motility; thus identifying the exact role of TbSAXO cannot
be defined without considering the functions of structural and
stabilizing proteins and the changes made after TbSAXO
knockdown.
In general, MT-based functions are regulated by the recruit-
ment of MAPs via regions carrying specific tubulin post-
translational modifications. In trypanosomes, tubulins are highly
post-translationally modified. In particular, acetylated tubulin was
identified in the flagellum and subpellicular MTs in T. cruzi [75]
and in the flagellum of T. brucei [76]. Also, these MTs are
glutamylated and tyrosinated but not glycylated [77,78,79]. By
expressing different domains of TbSAXO in mammalian cells and
in T. brucei, we have identified the MnL domains as necessary for
targeting, binding and stabilizing MTs and for targeting to the
flagellum. Since TbSAXO is a MAP, the post-translational status
of tubulins might be the ‘‘signal’’ or ‘‘code’’ required for TbSAXO
targeting to the microtubules of the axoneme and not the
microtubules of the cellular corset. Although other processes such
as intra-flagellar transport (IFT) could also be involved [80], even
though IFT has been recently demonstrated not to be specific to
ciliated/flagellated cells [81].
TbSAXO and the MAP6 protein share an N-terminal domain
carrying a cluster of cysteines, the Mn (or Mn-Like) modules, and
cold and nocodazole MT stabilizing property suggesting that
TbSAXO is a Map6-related protein. However, the differences in
the sequence of the IR regions, the number of repetitions of MnL
modules, and the absence of a strict consensus sequence for the N-
terminal domain suggest some functional differences. When
palmitoylated at the N-terminus, some MAP6s will localize to
the Golgi, although their exact function there is not clear [4].
TbSAXO was not observed at the Golgi complex in T. brucei nor
U-2 OS cells (our study) and was not identified in a T. brucei
Figure 5. The MnL domains are required for flagellum targeting and binding in T. brucei. Immuno-localization using WB (left panels) and
IF (right panels) of C-terminal, Myc-tagged, TbSAXO truncations after over-expression in PCF cells. WB panels: 3.10
6 whole cells (WC), cytoskeletons
(CK) and flagella (FG) were loaded on a 15% SDS-PAGE gel. The membranes were probed simultaneously with L8C4 (for PFR loading control) and anti-
Myc antibodies. Lanes 1–3: non-induced cells (2Tet). Lane 4–6: cells induced for over-expression (+Tet) for 24 h, except TbSAXO-1-35-Myc (c), which
was induced for 48 h. Immuno-fluorescence panels: cytoskeletons from over-expressing cells were probed with anti-Myc antibody. The kinetoplasts
and nuclei were labeled with DAPI. Expression of the Myc-recombinant proteins was induced for 6 h except for TbSAXO-36-213-Myc (g), which was
induced for 18 h. OF: old flagellum. NF: new flagellum. MS: mitotic spindle. Nuclei and kinetoplasts were labeled with DAPI. These results indicate that
the Mn domains are necessary and sufficient for targeting TbSAXO to the flagellum. Bar, 5 mm.
doi:10.1371/journal.pone.0031344.g005
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toylation. What could be the role of the N-terminal domain of
TbSAXO? When phosphorylated, the structural MAPs such as
tau, MAP2, MAP4 and MAP6-1 detach from MTs and can
interact with other proteins such as actin [10,83,84,85]. The
TbSAXO doublet band observed in our western-blots could reflect
phosphorylation of TbSAXO in both PCF and BSF. This is
supported by the phosphorylations observed at the N-terminus
(serine 8, serine 9 and tyrosine 12) in the phospho-proteome of
BSF [86]. There is no direct evidence of a MT-unbound form of
TbSAXO in our data but like other MAPs, TbSAXO could have a
modified MT-binding profile or structure in the phosphorylated
state thus modulating the rigidity of the MTs in response to
extracellular signals. Additionally, the presence of several proline-
recognition domains in TbSAXO could suggest interactions with
other flagellar proteins [54].
Until now MAP6 proteins have only been identified in
vertebrate cells. Axoneme localization and a role in flagellum
motility have not been described to date for any of the MAP6
proteins. Our databases/literature searches identified SAXO
orthologs from protozoan to mammals but only in ciliated/
flagellated organisms, with the exception of Cryptosporidium.A
specific role for SAXO proteins in cilia and flagella is strongly
suggested since proteomes of flagella of sperm cells (in rat, mouse
and drosophila), flagella of T. brucei, Chlamydomonas and cilia of
human airway cells have SAXO orthologs [20,87,88,89,90,91]. A
SAXO ortholog was identified in a total extract of C. elegans, which
has ciliated sensory neurons [92]. In contrast, no SAXO orthologs
was listed in the mouse photoreceptor neuron proteome. Map6
does appear in samples containing the cytoskeleton rootlet but not
in the sample containing only the axoneme [93]. Taken together
this points to a specific role for SAXO proteins in flagella and cilia
function. We predict that data generated from additional analyses
would clearly open new avenues in the study of this protein family,
and its role in axonemal function and diseases.
Materials and Methods
Ethics statement
All animal experiments were performed in accordance with
institutional guidelines as determined by the Service Commun des
Animaleries de l’Universite ´ Bordeaux Segalen (approval number
A33-063-916), which specifically approved the study. All exper-
iments requiring genetically modified organisms were carried out
with approval of the ethics committee of the Ministe `re de
l’Enseignement Supe ´rieur et de la Recherche (approval number
4946).
In silico analysis
SAXO orthologues were identified by walking BLASTP
(BLAST 2.2.26 [94,95,96]) using default parameters (non
redundant protein sequences database, BLOSUM 62 matrix,
gap cots existence: 11; extension: 1; conditional compositional
score matrix adjustment, no filter, no mask) and a cut-off E-value
of 4e-06 using initially TbSAXO or PfSAXO as query. Identified
proteins were then also used as query proteins.
Settings for MEME analysis [55] were: any number of repetition,
optimum width of each motif of 6 minimum and 30 maximum, 2
maximum motifs. Accession numbers of protein sequences used for
the MEME analysis are: Mus musculus Map6-1 (NP_034967.2), Mus
musculus Map6d1 (NP_941001.2), Mus musculus Saxo1 (NP_
001074565.1), Plasmodium falciparum PfSAXO (PFI0460w), Cryptospo-
ridium muris (XP_002141332.1), Eimeria tenella (SNAP00000003849),
Giardia lamblia (EFD95462.1), Paramecium tetraurelia_1 (XP_
001444884.1), Paramecium tetraurelia_2 (XP_001446307.1), Paramecium
tetraurelia_3 (XP_001430086.1), Tetrahymena thermophila_1 (XP_
001030650.1), Tetrahymena thermophila_2 (XP_001026633.1), Tetrahy-
mena thermophila_3 (XP_001025437.1), Toxoplasma gondii (XP_
002365452.1), Trypanosoma brucei brucei TbSAXO (XP_847454.1,
Tb927.8.6240), Trypanosoma cruzi (XP_817934.1), Trypanosoma congolense
(TcIL3000.8.6080), Leishmania major (XP_001683716.1).
Statistical analysis
In all experiments, error bars represent standard deviation (SE)
of samples in triplicates. Statistics in Figure 6g were performed
using an unpaired two-tailed t-test with a 90%, 95% or 99%
confidence interval. XLSTAT software (XLSTAT.com) was used
to determine P-values.
Cell lines, growth conditions and transfection
Genomic DNA of the T. brucei cell line TREU927/4
GUTat10.1 (a kind gift from S. Melville, Cambridge University)
selected by the genome project [97] was used to amplify by PCR
the ORFs of the proteins studied here. The work described in this
study uses the parental PCF and BSF T. brucei 427 strains (kind
gifts from G. Cross, Rockefeller University), co-expressing the T7
RNA polymerase and a tetracycline repressor, named in this study
as wild-type (WT) [98]. Over-expression and RNAi were induced
with 1 mg.mL
21 tetracycline. PCF trypanosomes (T. brucei 427 29–
13) were grown and transfected as in [99]. BSF trypanosomes (T.
brucei 427 90–13) were grown and transfected as in [100]. Special
care was taken to not keep in culture the selected PCF and BSF
transformants more than 2 weeks because of revertion over long-
term culture [101]. Transformants were screened by immuno-
fluorescence, after tetracycline induction and cloned by serial
dilution. Correct integration in the PCF mini chromosomes (MCs)
of the pPRP-177 vector was checked by pulsed-field electropho-
resis and southern-blot as described in [62,102]. Growth curves
were done by using a mallassez cell counter every 24 h and by
diluting the PCF cells back to 2.10
6 cells/ml and the BSF back to
3.10
5 cell/ml. Growth curves in Figure 6 represent the cumulative
cell number.
U-2 OS cells (human bone osteosarcoma epithelial cells,
ATCCH Number: HTB-96, [103]) were grown in D-MEM
Glutamax (Gibco) supplemented with 10% fetal calf serum and
1% Penicillin-Streptomycin at 37uC plus 5% CO2. Exponentially
Figure 6. TbSAXO RNAi knockdowns exhibit impaired flagellar motility. Inducible RNAi
TbSAXO in PCF (a, b, c, d) and BSF (e, f, g, h) cells.
Growth curves of PCF (a) and BSF (e) RNAi
TbSAXO cell lines. Corresponding WBs (PCF in b, BSF in f) of WT (parental), RNAi non-induced (-), and 24 h
and 96 h induced cells probed with mAb25 and L8C4 (anti-PFR2). For PCF 5.10
6 cells were used and 1.25610
5 cells for BSF. c. Sedimentation assay of
PCF RNAi. WT (closed squares). RNAi non-induced (2TET) (closed triangles) and induced (+TET) (open circles). d. Mobility graph obtained from Movie
S1. The positions of individual cells are plotted at 2.5 s intervals. Open circle: starting position of each cell. Arrowhead: ending position. Number in
parentheses: time in seconds of a given cell was within the field of view. Bar, 10 mm. g. Graph of cell populations with orthodox and unorthodox
kinetoplast number in BSF RNAi cultures (72 h of induction). K: kinetoplast. N: nucleus. Asterisks indicate statistical significance compared with the WT
population, and 2TET versus +TET condition (*P,0.1;* *P,0.05; ***P,0.01). h Electron-micrograph of a thin section of an aberrant BSF RNAi induced
cell (72 h). (*) indicates a flagellum. Scale bar, 2 mm. Error bars in a, c, e, and g represent the standard error from 3 independent experiments.
doi:10.1371/journal.pone.0031344.g006
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mine 2000 in OPTIMEM (Invitrogen) according to the manufac-
turer’s instructions and processed for IF 24 h post-transfection.
Plasmid construction
The TbSAXO ORF was amplified from T. brucei 927 genomic
DNA using the two specific primers EcoRI-1019 (59-
CCCGAATTCATGACAACATTGCACACTATTTCCAGCC-
39) and 1019-HindIII (59-AAAAAAGCTTCTAATCCGCAA-
TTTCTCCTGAGGGG-39) and cloned into pET28a+ (Novagen)
in frame with a N-terminal 6-histidine-tag making the pDRET1
plasmid used for bacterial expression and purification. To produce
the TbSAXO RNAi cell lines (PCF and BSF), a 650 bp insert was
amplified by PCR (primers 600PRP-XbaIBamHI 59-TTCA-
GAGGGATCCCTCGAGTCTAGAAAGTCACGAACGTCG-
GGCATCGATT-39 and HindIII-1019 59-AAAAGTTCGAA-
GCTTATGACAACATTGCACACTATTTCCAGCC-39) and
cloned into the p2T7-177 plasmid [62,102] thus providing
pPRP-177. We have checked the pPRP-177 vector by sequencing
the 177 pb repeat sequences, the promoter regions and the RNAi
target sequence. The NotI linearized plasmid was transfected in
PCF and BSF cells. For the expression of Myc-tagged TbSAXO,
the full-length TbSAXO ORF lacking the stop codon was cloned
into the HindIII-XbaI sites of pLew100X-Myc vector containing a
C-terminal 36Myc-tag and of a pLew100X-GFP plasmid
containing a C-terminal GFP (pLew100 vector from [98] modified
in the lab). For generation of truncated versions of TbSAXO, PCR
amplification of the desired TbSAXO sequence was performed to
yield fragments that encode aa 1–35, 36–213, 214–266, and
deletion of aa 2–35, 36–213 and 214–266. For deletion of aa 36–
213, an overlapping PCR was made using as template the
fragment encoding 1 to 35 aa and the fragment encoding aa 214 to
266 of TbSAXO. The PCR products were cloned into the HindIII-
XbaI sites of the aforementioned vectors and verified by
sequencing. To make the mammalian expression vectors for the
TbSAXO-Myc constructs, all Myc-tag ORFs were amplified by
PCR from the original pLew100X-Myc constructs (including the
stop-codon down-stream the 36Myc tag) and cloned directly into
the pcDNA3.1/CT-GFP TOPO mammalian (Invitrogen). Fused
domains MnL5-MnL6-Myc (aa 180–266-Myc) was amplified from
TbSAXO-Myc full-length in the pcDNA3.1/CT-GFP vector and
cloned into pcDNA3.1/CT-GFP. Mutation of the Cysteine-
Proline motif in MnL6* (C236P237 into Glycine236-Alanine237)
was done by site-directed mutagenesis following the instruction
from the Quickchange Site-directed mutagenesis Stratagene kit.
All DNA sequences were checked by DNA sequencing.
Bacterial expression and purification of 6His-TbSAXO
The BL21(DE3) (Novagen) bacterial strain, transformed with
pDRET1, was grown in 200 mL of LB+kanamycin (50 mg.mL
21)
to an OD600 nm of 0.5. Expression of the recombinant protein was
induced by adding 1 mM IPTG for 3 hours at 37uC. Cells were
harvested and resuspended in 20 mL 50 mM NaPi pH 7.0,
150 mM NaCl, then lysed by sonication. Cell debris and inclusion
bodies were pelleted by centrifugation (45006 g) for 30 min at
4uC. The pellet was resuspended in 20 mL 50 mM NaPi pH 7.2,
50 mM NaCl (buffer B), sonicated and washed twice in buffer B.
The recovered pellet was solubilized in 56 buffer B plus 8 M
Urea. The 6His-TbSAXO protein was purified on a 1.25 mL HIS-
Select
TM Cartridge (Sigma) Nickel affinity gel eluted with a
gradient of Imidazole (0 mM–250 mM) in buffer B plus 8 M urea.
The chosen fractions were pooled and dialyzed against buffer B
plus 8 M urea at 4uC.
Production of the anti-TbSAXO monoclonal antibody
100 mg of 6His-TbSAXO was emulsified with complete
Freund’s adjuvant (for first injection) or incomplete Freund’s
adjuvant (following boosts) and used to immunize two Balb/C
female mice (Charles River Laboratories, L’Arbresle, France).
Spleen cells of one mouse were fused to myeloma X63-Ag8 cells as
in [104]. One hybridoma producing a TbSAXO-specific antibody
was selected and named mAb25 (IgG2a).
T. brucei flagellar protein preparation
Flagellar proteins were prepared, separated in denaturing
conditions on a BIORAD ROTOFOR (ampholins 3–10) followed
by SDS-PAGE electrophoresis as in [52]. After Coomassie
staining, two protein bands were excised, trypsin-digested and
subjected to LC-MS/MS.
Western blots
Proteins were prepared in Laemmli buffer [105] separated by
SDS-PAGE (10, 12 or 15% acrylamide) and transferred onto
PVDF membranes. Membranes were processed as in [99]. After
washes in Tris buffer saline (TBS), 0.2% Tween-20 then TBS,
membranes were washed in TBS and revealed with 0.05%
diaminobenzidine, 0.015% H2O2 or ECL (Immobilon Millipore)
according to the manufacturer’s instructions. The primary
antibodies used were the anti-TbSAXO monoclonal mAb25
(1:1000), anti-PFR2 L8C4 (1:1000), anti-cMyc 1:200 (Santa Cruz
SC-40), and the secondary antibody was an IgG+IgM HRP-
conjugated 1:10,000 (Jackson, 115-035-044).
Sedimentation assays and video-microscopy
Sedimentation assays were done as in [23]. Briefly, WT, non-
induced (2tetracycline) and induced (+tetracycline) RNAi
TbSAXO
cells were grown for 24 h then placed in cuvettes. The OD600 nm
was measured at t=0 and t=24 h before (ODb) and after (ODa)
mixing. The graph represents the percentage of sedimentation
calculated as 100-(ODb/ODa 6100). Video-microscopy was
carried out as described in [106]. Briefly, PCF cells (WT cell
and RNAi
TbSAXO cells after 72 h of induction) were washed in PBS
and flagellum motility and cell mobility were recorded by phase
contrast on a Zeiss AxioImager, 1006lens (NA 1.4) and 406(NA
1.3) respectively. 35 s or 184 s of digital video from separate
regions were captured and analyzed using MetamorphH software
(Molecular Devices).
Immuno-fluorescence
T. brucei cells. T. brucei PCF cells were treated as in [52] and
fixed in paraformaldehyde 3% in PBS. BSF cytoskeletons were
prepared by washing the cells in vPBS (PBS, sucrose 15.7 g.L
21,
glucose 1.8 g.L
21), then gently resuspending in PIPES 100 mM
pH 6.9, MgCl2 1 mM, NP-40 0.25% and directly loading them on
poly-L-lysine-coated slides and finally fixed in methanol (220uC,
30 min). After rehydration in PBS the slides were incubated 1 hour at
room temperature with primary antibodies in a dark moist chamber
followed by two washes (5 min) in PBS then incubation in the
secondary antibody (1 h). After two 5 min washes in PBS, DNA was
labeled 5 min with DAPI (10 mg.mL
21) followed by 2 PBS washes.
Slides were mounted with SlowfadeH Gold Kit (Molecular Probes, S-
36936). Combination labeling was as follows: for localization of the
TbSAXO Myc-tag proteins we used monoclonal anti-Myc 1:20
(Santa-cruz sc-40) and anti-mouse IgG (H+L) Alexafluor-594
conjugated (Molecular probes A21201, 1:400); for triple labeling
(TbSAXO, PFR and flagellar transition zone), we used
simultaneously mAb25 1:5 (IgG2a); anti-PFR2 neat (L8C4, IgG1),
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Secondary antibodies used were: anti-mouse IgG2a specific
Alexafluor-488 conjugated (Molecular probes, A-21131, 1:400),
anti-mouse IgG1 specific Alexafluor-594 conjugated (Molecular
probes, A-21125, 1:400) and anti-rabbit IgG (H+L) Alexafluor-594
(Molecular probes, A-11012, 1:400). It is noteworthy that the IF
studies of TbSAXO-Myc constructs were done after short induction
times (6 h, except TbSAXO-36-213-Myc which was induced 18 h),
to avoid cellular saturation with recombinant proteins.
U-2 OS cells. For the MT stability assays in U-2 OS cells at
37uC and 4uC (cells were incubated 30 min at 4uC), all solutions
were pre-warmed at 37uC or cooled at 4uC, including the fixation
step; alternatively cells were incubated in medium supplemented
with 20 mM nocodazole 30 min, 37uC, to induce MT
depolymerization. For observation of whole cells, cells grown on
coverslips were washed briefly with 30 ml of EMT buffer (PIPES
60 mM, HEPES 25 mM, EGTA 10 mM, MgCl2 10 mM adjusted
to pH 6.9 with KOH) and fixed in paraformaldehyde 3% in EMT
for 15 minutes (at 37uCo r4 uC). To remove soluble proteins
(including non-MT associated proteins), cells were briefly extracted
for 2 min with 30 ml of EMT, TX-100 0.5%, glycerol 10% then
fixed in paraformaldehyde (at 37uCo r4 uC, 15 min). Cells were
neutralized 10 min inglycine (100 mMinPBS). Aftertwo washesin
PBS, cells were incubated in PB (PBS, 10% fetal calf serum, 0.01%
saponin) for 10 minutes. Primary antibodies anti-cMyc (rabbit
polyclonal Sigma c-3956, 1:100) and anti-tubulin (TAT1, 1:100,
[107]) were added for 1 hour in a dark moist chamber. After two
PBS washes, cells were incubated for 1 hour with the secondary
antibodies: anti-rabbit FITC conjugated (sigma F-9887, 1:400) and
anti-mouse IgG (H+L) Alexafluor-647 conjugated (Molecular
probes, A-21235, 1:400) respectively. The nuclei were stained
withDAPI (1 mg.mL
21 in PBSfor 5 minutes) and cells were washed
and mounted as described above.
Images were acquired on a Zeiss Imager Z1 microscope, using a
Photometrics Coolsnap HQ2 camera, at 1006 or 636 (NA 1.4)
with MetamorphH software (Molecular Devices), and processed
with ImageJ.
Electron microscopy and immuno-electron microscopy
Cells were prepared as in [99] with the following changes: 50 mL
of log phase BSF WT and RNAi
TbSAXO cells (72 hours induction)
were used. Cells were fixed in 25 mL of 4% glutaraldehyde, 4%
paraformaldehyde, and 0.5% tannic acid, in 0.1 M cacodylate buffer
pH 7.4. Immuno-labeling of flagella was done as follows. Flagella
were prepared as in [52] and resuspended at 1.7610
7 flagella/mL.
Ten mL of purified flagella were mixed with 100 mLo fP B Sa n dp l a c e
on a sheet of clean Parafilm. Charged Butvar and carbon-coated
nickel grids (EMS G200-Ni) were floated onto the droplet for
15 minutes.The flagellawerefixed bytransferring the grids to 500 ml
of 2% Paraformaldehyde, 0.025% Glutaraldehyde in PBS for
30 min. Grids were then neutralized by transferring to 500 ml
droplets of 100 mM Glycine in PBS 2610 min. Grids were
transferred to 30 mL of mAb25 (neat) for 4 hours. The grids were
washed (three times10 minutes)in PBS and then incubated on 30 mL
drop of 10 nm gold conjugate protein A (Aurion) (diluted 1:10 in
PBS, overnight at 4uC). Grids were then washed 4610 min in PBS,
then fixed 30 minutes in 100 mL droplets of 2.5% glutaraldehyde in
distilled water, washed 465 min on 500 mL droplets of water, and
negatively stained (NanoVan, Nanoprobes; 40 mL grid).
Supporting Information
Figure S1 The U-2 OS cell line is a valid model for the
cold- and nocodazole-induced MT depolymerization
test. The MTs of U-2 OS cells were labeled with anti-tubulin
and nuclei with DAPI. A. IF on mock transfected U2-OS cells
subjected to 37uC/4uC treatment and a short extraction before
fixation. B. MAP6-1-GFP (b), TbSAXO-Myc (c) or various
truncated versions (d–f) and a mutated version of TbSAXO-Myc
(g) was expressed in U-2 OS cells and tested by IF after nocodazole
treatment. In each panel, the last columns are merged images.
Scale bars represent 20 mm.
(TIF)
Figure S2 IF on U-2 OS whole cells expressing TbSAXO-
Myc truncations or MAP6-1-GFP. Experimental conditions
were as in Figure 4 except that the cells were fixed before
permeabilization in order to visualize the soluble pool of the
recombinant proteins and to demonstrate their expression. In each
temperature regime, the left column shows tubulin (red), the center
column shows the recombinant protein (green), and the right
column the merged images. Scale bar represents 20 mm.
(TIF)
Figure S3 IF on T. brucei whole cells expressing
TbSAXO-Myc truncations. Experimental conditions were as
in Figure 5 except that the cells were fixed before permeabilization
to visualize the soluble pool of the recombinant proteins and
demonstrate their expression. Scale bar represents 5 mm.
(TIF)
Figure S4 IF of TbSAXO RNAi cells lines. PCF (A) and BSF
(B) cytoskeletons of WT, non-ind (NInd) and Induced (Ind) cells
probed by IF with mAb25 and L8C4. A. a to r: TbSAXO
labelling with mAb25. a9 to r9: PFR2 labelling with L8C4. a–c:
2K2N wild-type cell. d–f: Non induced 2K2N cell showing that
mAb25 labeling is partial. g–i: 24 h induced 2K2N cell. j–l:4 8h
induced 2K2N cell. m–o: 48 h induced 2K1N multi-flagellated
cell. p–r: 48 h induced 2 K zoid cell. a9–c9: 2K2N wild type cell.
d9–f9: Non induced 2K2N cell. g9–i9: 24 h induced 2K1N cell. j9–
l9: 24 h induced 2K1N cell. m9–o9: 48 h induced xKxN cell. p9–
r9: 24 h induced 1 K zoid cell. B. a to r: TbSAXO labeling with
mAb25. a9 to r9: PFR2 labeling with L8C4. a–c: 2K2N wild type
cell. d–f: Non induced 2K2N cell showing that mAb25 labelling is
weaker than in wild-type cells. g–i: 24 h induced 2K2N cell
showing that the new flagellum is not labelled. j–l: 24 h induced
2K2N cell. m–o: 72 h induced multi-flagellated cell showing that
some flagella are not labelled. p–r: 72 h induced 1 K zoid cell. a9–
c9: 2K2N wild type cell. d9–f9: Non induced 2K1N cell. g9–i9:
24 h induced 2K2N cell. j9–l9: 24 h induced 4K2N cell. m9–o9:
24 h induced xKxN cell. p9–r9: 24 h induced 2 K zoid cell. Scale
bar represents 5 mm.
(TIF)
Figure S5 SAXO orthologues were identified from
protozoa to mammals. Settings for MEME analysis were:
any number of repetition, optimum width of each motif of 6
minimum and 30 maximum, 2 maximum motifs. Accession
numbers of proteins used for the MEME analysis are: Mus musculus
Map6-1 (NP_034967.2), Mus musculus Map6d1 (NP_941001.2),
Gallus gallus MAP6 (NP_990250.1), Xenopus tropicalis MAP6 (NP_
001120222.1), Dano rerio MAP6 (XP_002664657.1), Mus musculus
SAXO1 (NP_001074565.1), Gallus gallus SAXO1 (XP_424824.1),
Xenopus tropicalis SAXO (NP_998882.1), Dano rerio SAXO (NP_
001032667.1), Trichoplax adhaerens SAXO (XP_002114668.1),
Drosophila melanogaster SAXO (NP_650706), Strongylocentrotus purpur-
atus SAXO (XP_787867.1), Ciona intestinalis SAXO (XP_
002127009.1), Caenorharbditis elegans SAXO (NP_492403,
T08G11.3), Nematostella vectensis SAXO (XP_001640941.1), Physcomi-
trella patens SAXO1 (XP_001761920.1), Physcomitrella patens SAXO2
TbSAXO, a MAP6-Related Protein in T. brucei
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FAP257), Paramecium tetraurelia SAXO1 (XP_001444884.1), Parame-
cium tetraurelia SAXO2 (XP_001427791.1), Paramecium tetraurelia
SAXO3 (XP_001430086), Cryptosporidium muris SAXO (XP_
002141332.1), Plasmodium falciparum SAXO (XP_001351967.1,
PFI0460W), Trypanosoma brucei SAXO (XP_847454.1, Tb927.8.6240),
Leishmania major SAXO (XP_001683716.1). A. MEME analysis,
including SAXO orthologues from protozoa to mammals but also
MAP6proteinsfromdifferentvertebrates,identifiedthemotif1(inred),
motif 2a (dark blue), and motif 2b (light blue). B. Position-specific
probability matrix derived from the MEME analysis for motif 1, motif
2a and motif 2b and their respective regular expression. In this wide-
range analysis, the initial motif 2 identified in Figure 1B is, here,
identifiedas2divergentmotifs(motif2aand2b)butwherethesequence
PFEGE[TS][TN]Y[RK]S[DE][FY]GP[KW] is well conserved (in
red).
(TIF)
Figure S6 The N-terminus domain of TbSAXO is not
involved in Golgi targeting. Immuno-fluorescence on U-2 OS
cells not transfected (a) or expressing (in green, labelled with anti-
Myc) TbSAXO-Myc (b), the N-terminus (1–35)-Myc (c) or the
deletion construct D2-35-Myc (d) co-stained with the Golgi marker
anti-Giantin (in red) [108]. Nuclear DNA is labeled with DAPI.
Bar, 8 mm.
(TIF)
Movie S1 Illustration of cell mobility of WT cells followed by
RNAi induced cells (72 h) confirming the flagellum motility defect
of the RNAi
TbSAXO cells, which remained primarily in one location
whilst the WT cells travelled long distances.
(MOV)
Movie S2 Illustration of the flagellar beating of a WT cell
followed by a 72 h RNAi
TbSAXO induced cell showing that
RNAi
TbSAXO cells were not paralyzed, but the flagellar beat
appeared uncoordinated, and slower when compared to WT.
(MOV)
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